Rhabdomyolysis associated with fenofibrate monotherapy in a patient with chronic myelogenous leukemia

Kazuya Kato, Astushi Nagase, Minoru Matsuda, Yurina Kato, Kazuhiko Onodera, Takako Kawakami, Mineko Higuchi, Yoshiaki Iwasaki, Masahiko Taniguchi, Hiroyuki Furukawa

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Rhabdomyolysis associated with fenofibrate monotherapy is extremely rare. Here, we report a rare case of rhabdomyolysis of the psoas muscle in an 82-year-old man with chronic myelogenous leukemia (CML). He was prescribed fenofibrate because of a hypertriglyceridemia. The patient reported generalized muscle pain and right abdominal pain while receiving fenofibrate monotherapy. An abdominal computed tomography scan and an abdominal ultrasound showed a large and low attenuation and high echogenicity, respectively, in the right middle abdominal area. Laboratory values included a serum creatine concentration of 4.1 mg/dl and a creatinine phosphokinase concentration of 5,882 IU/l. During laparotomy, a large hematoma and necrotic mass was identified in the right psoas muscle. Histological examination revealed that the resected specimens were of the psoas muscle with irregular fiber sizes, degenerating fibers surrounding the inflammatory reaction, and fiber necrosis that is typical for polymyositis. Based on these findings and the clinical history, a diagnosis of fenofibrate-induced rhabdomyolysis was made. To the best of our knowledge, no patient has ever been diagnosed with fulminant psoas rhabdomyolysis due to a fenofibrate monotherapy. This report details the rare case of rhabdomyolysis in a patient with CML associated with fenofibrate monotherapy and offers a review of the literature.

Original languageEnglish
Pages (from-to)492-496
Number of pages5
JournalCase Reports in Gastroenterology
Volume5
Issue number2
DOIs
Publication statusPublished - May 2011

Fingerprint

Fenofibrate
Rhabdomyolysis
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Psoas Muscles
Polymyositis
Creatine
Hypertriglyceridemia
Myalgia
Hematoma
Laparotomy
Abdominal Pain
Creatinine
Necrosis
Phosphotransferases
Tomography
Serum

Keywords

  • Chronic myelogenous leukemia
  • Fenofibrate monotherapy
  • Psoas muscle
  • Rhabdomyolysis
  • Surgery

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Kato, K., Nagase, A., Matsuda, M., Kato, Y., Onodera, K., Kawakami, T., ... Furukawa, H. (2011). Rhabdomyolysis associated with fenofibrate monotherapy in a patient with chronic myelogenous leukemia. Case Reports in Gastroenterology, 5(2), 492-496. https://doi.org/10.1159/000331559

Rhabdomyolysis associated with fenofibrate monotherapy in a patient with chronic myelogenous leukemia. / Kato, Kazuya; Nagase, Astushi; Matsuda, Minoru; Kato, Yurina; Onodera, Kazuhiko; Kawakami, Takako; Higuchi, Mineko; Iwasaki, Yoshiaki; Taniguchi, Masahiko; Furukawa, Hiroyuki.

In: Case Reports in Gastroenterology, Vol. 5, No. 2, 05.2011, p. 492-496.

Research output: Contribution to journalArticle

Kato, K, Nagase, A, Matsuda, M, Kato, Y, Onodera, K, Kawakami, T, Higuchi, M, Iwasaki, Y, Taniguchi, M & Furukawa, H 2011, 'Rhabdomyolysis associated with fenofibrate monotherapy in a patient with chronic myelogenous leukemia', Case Reports in Gastroenterology, vol. 5, no. 2, pp. 492-496. https://doi.org/10.1159/000331559
Kato, Kazuya ; Nagase, Astushi ; Matsuda, Minoru ; Kato, Yurina ; Onodera, Kazuhiko ; Kawakami, Takako ; Higuchi, Mineko ; Iwasaki, Yoshiaki ; Taniguchi, Masahiko ; Furukawa, Hiroyuki. / Rhabdomyolysis associated with fenofibrate monotherapy in a patient with chronic myelogenous leukemia. In: Case Reports in Gastroenterology. 2011 ; Vol. 5, No. 2. pp. 492-496.
@article{8a22c9958b77427eb2da79cb9205879e,
title = "Rhabdomyolysis associated with fenofibrate monotherapy in a patient with chronic myelogenous leukemia",
abstract = "Rhabdomyolysis associated with fenofibrate monotherapy is extremely rare. Here, we report a rare case of rhabdomyolysis of the psoas muscle in an 82-year-old man with chronic myelogenous leukemia (CML). He was prescribed fenofibrate because of a hypertriglyceridemia. The patient reported generalized muscle pain and right abdominal pain while receiving fenofibrate monotherapy. An abdominal computed tomography scan and an abdominal ultrasound showed a large and low attenuation and high echogenicity, respectively, in the right middle abdominal area. Laboratory values included a serum creatine concentration of 4.1 mg/dl and a creatinine phosphokinase concentration of 5,882 IU/l. During laparotomy, a large hematoma and necrotic mass was identified in the right psoas muscle. Histological examination revealed that the resected specimens were of the psoas muscle with irregular fiber sizes, degenerating fibers surrounding the inflammatory reaction, and fiber necrosis that is typical for polymyositis. Based on these findings and the clinical history, a diagnosis of fenofibrate-induced rhabdomyolysis was made. To the best of our knowledge, no patient has ever been diagnosed with fulminant psoas rhabdomyolysis due to a fenofibrate monotherapy. This report details the rare case of rhabdomyolysis in a patient with CML associated with fenofibrate monotherapy and offers a review of the literature.",
keywords = "Chronic myelogenous leukemia, Fenofibrate monotherapy, Psoas muscle, Rhabdomyolysis, Surgery",
author = "Kazuya Kato and Astushi Nagase and Minoru Matsuda and Yurina Kato and Kazuhiko Onodera and Takako Kawakami and Mineko Higuchi and Yoshiaki Iwasaki and Masahiko Taniguchi and Hiroyuki Furukawa",
year = "2011",
month = "5",
doi = "10.1159/000331559",
language = "English",
volume = "5",
pages = "492--496",
journal = "Case Reports in Gastroenterology",
issn = "1662-0631",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Rhabdomyolysis associated with fenofibrate monotherapy in a patient with chronic myelogenous leukemia

AU - Kato, Kazuya

AU - Nagase, Astushi

AU - Matsuda, Minoru

AU - Kato, Yurina

AU - Onodera, Kazuhiko

AU - Kawakami, Takako

AU - Higuchi, Mineko

AU - Iwasaki, Yoshiaki

AU - Taniguchi, Masahiko

AU - Furukawa, Hiroyuki

PY - 2011/5

Y1 - 2011/5

N2 - Rhabdomyolysis associated with fenofibrate monotherapy is extremely rare. Here, we report a rare case of rhabdomyolysis of the psoas muscle in an 82-year-old man with chronic myelogenous leukemia (CML). He was prescribed fenofibrate because of a hypertriglyceridemia. The patient reported generalized muscle pain and right abdominal pain while receiving fenofibrate monotherapy. An abdominal computed tomography scan and an abdominal ultrasound showed a large and low attenuation and high echogenicity, respectively, in the right middle abdominal area. Laboratory values included a serum creatine concentration of 4.1 mg/dl and a creatinine phosphokinase concentration of 5,882 IU/l. During laparotomy, a large hematoma and necrotic mass was identified in the right psoas muscle. Histological examination revealed that the resected specimens were of the psoas muscle with irregular fiber sizes, degenerating fibers surrounding the inflammatory reaction, and fiber necrosis that is typical for polymyositis. Based on these findings and the clinical history, a diagnosis of fenofibrate-induced rhabdomyolysis was made. To the best of our knowledge, no patient has ever been diagnosed with fulminant psoas rhabdomyolysis due to a fenofibrate monotherapy. This report details the rare case of rhabdomyolysis in a patient with CML associated with fenofibrate monotherapy and offers a review of the literature.

AB - Rhabdomyolysis associated with fenofibrate monotherapy is extremely rare. Here, we report a rare case of rhabdomyolysis of the psoas muscle in an 82-year-old man with chronic myelogenous leukemia (CML). He was prescribed fenofibrate because of a hypertriglyceridemia. The patient reported generalized muscle pain and right abdominal pain while receiving fenofibrate monotherapy. An abdominal computed tomography scan and an abdominal ultrasound showed a large and low attenuation and high echogenicity, respectively, in the right middle abdominal area. Laboratory values included a serum creatine concentration of 4.1 mg/dl and a creatinine phosphokinase concentration of 5,882 IU/l. During laparotomy, a large hematoma and necrotic mass was identified in the right psoas muscle. Histological examination revealed that the resected specimens were of the psoas muscle with irregular fiber sizes, degenerating fibers surrounding the inflammatory reaction, and fiber necrosis that is typical for polymyositis. Based on these findings and the clinical history, a diagnosis of fenofibrate-induced rhabdomyolysis was made. To the best of our knowledge, no patient has ever been diagnosed with fulminant psoas rhabdomyolysis due to a fenofibrate monotherapy. This report details the rare case of rhabdomyolysis in a patient with CML associated with fenofibrate monotherapy and offers a review of the literature.

KW - Chronic myelogenous leukemia

KW - Fenofibrate monotherapy

KW - Psoas muscle

KW - Rhabdomyolysis

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=80052741101&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052741101&partnerID=8YFLogxK

U2 - 10.1159/000331559

DO - 10.1159/000331559

M3 - Article

C2 - 21960954

AN - SCOPUS:80052741101

VL - 5

SP - 492

EP - 496

JO - Case Reports in Gastroenterology

JF - Case Reports in Gastroenterology

SN - 1662-0631

IS - 2

ER -